AN ACT FOR THE UNIVERSITY OF ARKANSAS AND THE DIVISION OF AGRICULTURE - ARKANSAS BIOSCIENCES INSTITUTES APPROPRIATION FOR THE 2026-2027 FISCAL YEAR.
HB1075 is an annual appropriation bill for the University of Arkansas and the Division of Agriculture’s Arkansas Biosciences Institute for fiscal year 2026-2027. It authorizes a total of $2,375,563 for the University of Arkansas - Arkansas Biosciences Institute and $2,415,432 for the Division of Agriculture - Arkansas Biosciences Institute, covering regular salaries, matching funds, operating expenses, travel, professional fees, and capital outlay. The bill draws funding from the Arkansas Biosciences Institute Program Account of the Tobacco Settlement Program Fund.
In addition to setting the dollar amounts, the bill includes standard fiscal controls and special language governing how the money may be used. It restricts transfers under Arkansas Code 19-4-513 except as specifically allowed in the act, permits certain line-item transfers only with approval from the Division of Higher Education, the Chief Fiscal Officer, and the Legislative Council or Joint Budget Committee, and clarifies that tobacco-settlement-funded positions are not guaranteed to continue if those funds are insufficient. The act also states that state funds will not automatically replace expiring tobacco settlement funds unless separately appropriated and authorized.
The bill’s impact on state law is limited to appropriating funds and establishing temporary, non-codified budget conditions for the 2026-2027 fiscal year. It does not create a new permanent program or amend substantive policy law; instead, it operates as a one-year spending authorization with oversight provisions tied to existing state fiscal and purchasing laws. The emergency clause makes the act effective July 1, 2026, so the appropriations are available at the start of the fiscal year.
The general sentiment around the bill appears neutral to supportive, consistent with a routine budget measure that moved through the legislative process and was enacted as Act 62. Because no committee transcript or recorded vote details are provided, there is no evidence of significant public debate or opposition in the available materials. The bill’s structure suggests it was treated as a standard appropriations item rather than a controversial policy proposal.
Notable points of potential contention are the transfer restrictions, the requirement for legislative approval of certain appropriation shifts, and the language limiting any expectation that tobacco settlement funds will be backfilled with state general funds. These provisions reflect a balance between operational flexibility for the university and continued legislative oversight of spending.
HB1075 appropriates a combined $4,790,995 for the University of Arkansas and Division of Agriculture Arkansas Biosciences Institute operations for fiscal year 2026-2027, funded through the Tobacco Settlement Program Fund. It temporarily governs salary, operating, travel, professional services, and capital outlay spending, while imposing fiscal controls, transfer limits, and nonreplacement language for tobacco-settlement-funded positions. The bill affects the University of Arkansas system, the Division of Agriculture, and the state budget process, but it does not permanently amend the Arkansas Code beyond the fiscal year covered by the act.
The available record indicates a routine, noncontroversial appropriations measure that was enacted as Act 62. With no committee transcript or vote breakdown provided, there is no sign of organized opposition or extended debate in the materials. The overall sentiment appears pragmatic and supportive, reflecting standard legislative approval of higher-education and biosciences funding.
The main points of contention embedded in the bill are fiscal rather than ideological: restrictions on transferring appropriations, the need for approval from the Division of Higher Education, the Chief Fiscal Officer, and legislative budget committees, and the explicit statement that tobacco settlement funds do not obligate the state to continue positions if those funds decline. These provisions may concern administrators seeking flexibility and legislators seeking oversight, but no specific objections are documented in the provided context.